PBE vs AAPL: Which Stock is Better?
Side-by-side comparison of Invesco Biotechnology & Genome Etf and Apple Inc in 2026
PBE
Invesco Biotechnology & Genome Etf
$81.17
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | PBE | AAPL | Winner |
|---|---|---|---|
| Market Cap | N/A | N/A | Tie |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze PBE
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBE or AAPL a better investment?
Comparing PBE and AAPL: Invesco Biotechnology & Genome Etf has a market cap of N/A while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBE and AAPL?
PBE (Invesco Biotechnology & Genome Etf) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBE or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PBE or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for PBE.
Which company is more profitable: PBE or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for PBE.
Which is the larger company: PBE or AAPL?
Apple Inc (AAPL) is larger with a market cap of N/A compared to N/A for PBE.
Should I buy PBE or AAPL in 2026?
Both PBE and AAPL have investment merit. PBE trades at $81.17 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBE and AAPL stock?
Key differences: Market Cap (N/A vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).